Journal of Next-Generation Research 5.0 (JNGR 5.
0)
Website: www.jngr5.com Email: [email protected]
Role of AI, Automation & Robotics in
Pharmaceutical Industry
Sivasakthivel Periyannan Ramamoorthy
Director of Automation at CVS Health, Texas, United States
Abstract:
The pharmaceutical industry is undergoing a massive transformation driven by technological
advancements and leapfrogging further due to the integration of Artificial intelligence (AI), automation,
and robotics. These technologies are being deployed to cover various aspects, including drug discovery,
manufacturing, supply chain, and patient care. AI's ability to process and analyze massive data sets allows
researchers to identify new drug candidates faster or improve on current ones through various strategies.
Automation transforms repetitive tasks and increases accuracy, but most importantly, it frees people up
from work that they need not do and concentrates on the jobs that still require human involvement.
Conversely, when integrated with AI, robots enhance the production process by enabling speedy,
accurate, and scalable manufacturing. Robotics are now being used in pharmacies for medication
dispensing and are very efficient. Furthermore, All these innovations driven by AI, Automation, and
robotics also contribute to personalized medicine by extending tailored treatments based on individual
patient data. This paper explores the role of AI, Automation, and Robotics in the Pharmaceutical industry
and its benefits. The ongoing evolution of such technologies holds immense potential to address the
growing needs and handle industry challenges such as increasing demand, regulatory compliance, and
global health needs to ultimately lead the pharmaceutical industry towards a more efficient, adaptive, and
patient-centered approach.
Keywords- AI, Automation, Robotics, Pharmaceutical industry, Drug discovery, Manufacturing
efficiency
Introduction
The pharmaceutical industry is witnessing a massive transformation using AI, Automation, and robotics
technologies. Pharma companies are a critical pillar of the global healthcare ecosystem with rapid
growth. However, it is increasingly under pressure from rising healthcare costs, productivity targets, and
the quest for personalized medicines. Traditional drug discovery, manufacturing, and distribution
methods, with high labor requirements, are often tedious and expensive. Artificial Intelligence (AI)
combined with automation and robotics create an entirely new way of coping with these old problems.
Using the most advanced data processing and analysis tools, machine learning, and forecast models, AI
speeds up drug development. It adds better designs to clinical trials and sets new performance standards
for therapeutics. For pharmaceutical manufacturing, automation has cut back on repetitive work,
Volume 1, Issue 1, November-December 2024
1
Journal of Next-Generation Research 5.0 (JNGR 5.0)
Website: www.jngr5.com Email: [email protected]
increased uniformity, and reduced human error, which means more reliable, higher quality, and efficient
products. Robotics, many of them AI-driven, have revolutionized production processes through broader
capacity and higher precision. The pharmaceutical industry can benefit from these advancements
regarding global health needs. They play a vital role in enhancing supply chain systems, adhering to
compliance with regulations at different levels, and cultivating customized healthcare solutions. The
ongoing development of these technologies will be accompanied by unprecedented opportunities for
increasing the speed, cost-effectiveness, and safety of pharmaceutical operations. They may further open
a new era in treatment methods to offer innovative therapies. AI use in the pharmaceutical industry has
increased over the last few years and is expected to grow more. AI can save time and money while
providing better results for the formulations and process parameters in the development of drugs (1).
Figure 1: Artificial Intelligence market in sectors of medical diagnostics, personal AI assistants,
drug discovery, and genomics.
As shown in Fig.1, the AI market is rapidly rising, increasing from $200 million in 2015 to $700 million
in 2018, and is expected to rise to $5 billion by 2024. A mind-boggling 40% exponential growth of
compound annual growth rate between 2017 and 2024 shows us how AI will revolutionize the pharma
and allied sectors shortly (2).
Role of AI in Pharmaceutical Industry
The advent of AI into mainstream application development and integration with its capabilities has
opened a new frontier for the Pharmaceutical Industry. This technology helps pharmaceutical companies
foster innovation while improving efficiency at scale.
A few of the areas where AI is used in the Pharmaceutical industry are :
The process of discovering and developing drugs:
Companies deploy different machine-learning algorithms to analyze complex data. Such data typically
includes biological data, identifies potential drug targets, and predicts how molecules interact with other
biological systems. Using machine learning techniques speeds up the screening of new drug candidates
and simplifies the early stages of the experimental research process. Predictive models for drug efficacy,
safety, and toxicity can reduce preclinical testing using machine learning algorithms.
Volume 1, Issue 1, November-December 2024
2
Journal of Next-Generation Research 5.0 (JNGR 5.0)
Website: www.jngr5.com Email: [email protected]
Clinical Trials: AI helps to design a better clinical trial because it establishes more optimal recruitment
of patients and selects the appropriate ones based on genetic, demographic and clinical data. It cuts down
recruitment times and helps reach the relevant participants.
AI enables continuous monitoring of clinical trial data, flagging early signs of safety concerns or efficacy
problems and making trials faster, cheaper, and more efficient.
Personalized Medicine: By analyzing data from patients (genomics, history of previous diseases, etc.),
AI helps identify the best therapies for each patient and optimizes treatment outcomes while minimizing
side effects.
Drug Repurposing: Artificial intelligence algorithms are capable of scouring databases of medications to
repurpose existing drugs. Particularly when a disease is newly emerging, this can expedite the
development of new therapies into the marketplace.
Pharmacovigilance: AI tools play a critical role by discovering adverse effects from social media,
healthcare data, and clinical reports to monitor drug safety post-approval. Enabling them to respond faster
to potential safety issues.
AI is expeditiously penetrating the healthcare sector and significantly impacts clinical decision-making,
disease diagnosis, and automation (3). AI has opportunities to explore further in pharmaceutical and
healthcare research because of its ability to investigate enormous amounts of data from various modalities
(4). Some current studies elaborate on the utilization of AI in healthcare and other sectors. The AI
technologies in the healthcare industry include machine learning (ML), natural language processing
(NLP), physical robots, and robotic process automation (5). In ML, neural network models and deep
learning with various features are being applied to imaging data to identify clinically significant elements
early, especially in cancer-related diagnoses (6,7).
Figure 2: AI Applications in Healthcare: Advancing Clinical Decision-Making, Diagnosis, and
Automation through Data Analysis.
AI has the potential to derive a meaningful relationship within the raw datasheets that can be further used
in the diagnosis, treatment, and mitigation of the disease. A variety of newer techniques that are used for
Volume 1, Issue 1, November-December 2024
3
Journal of Next-Generation Research 5.0 (JNGR 5.0)
Website: www.jngr5.com Email: [email protected]
computational understanding in this emerging field have the potential to be applied in almost every field
of medical science. The complex clinical problems must be solved with the challenge of acquiring,
analyzing, and applying vast knowledge (Figure 2) (8).
Role of Automation in Pharmaceutical Industry
Automation is also a key function for pharma companies to improve operational efficiencies and the
consistency of production and compliance.
A few areas where automation is widely used in the Pharmaceutical industry are :
Manufacturing Efficiency: Businesses can use automation to simplify repetitive manufacturing
processes like packaging, labeling, and filling. It decreases the requirement for manual work, limits
mistakes, and guarantees short production cycles. That ensures consistent and automated quality control
and adherence to standard practices.
Supply Chain & inventory: Adding automation benefits the pharmaceutical industry immensely.
Automation techniques can optimize the stocks needed based on forecasting models, thereby reducing
losses due to wastage. Automation also plays a pivotal role in warehouse management more efficiently,
making storage and retrieval processes easier. In distribution, pharmaceutical companies can reduce delay
by ensuring the right drugs are dispatched to the right provider in a timely manner and outlining the most
efficient path to market.
Regulatory Compliance: Automation tools provide error-free records management, audit trail
management, and automated reporting processes, ensuring compliance with regulations in pharmaceutical
operations. Production Automated systems monitor environmental conditions, batch records, and other
critical parameters in real time to ensure compliance with regulatory requirements.
Packaging and Labelling: Automation accelerates the packaging and labeling process, enabling a drug
to get a label containing details about dosage, instructions, etc. All these are done under the supervision of
sensors that ensure there is no labeling error. This minimizes human errors and enhances the safety of the
product.
Pharmaceutical claim management: One key area where automation offers immense value is claims
management. By implementing automation, pharmaceutical companies can streamline reimbursement,
insurance, and claims handling processes, significantly reducing human error while ensuring compliance
with regulatory standards. Furthermore, in the claim management process, pharma companies can
automate right from tracking claims from submission to resolution while verifying patient’s eligibility,
managing documentation, and ensuring timely reimbursements. Automation not only helps to facilitate
the workflow but also allows claim status tracking and monitoring, resulting in lesser administrative costs
and higher customer satisfaction. Ultimately, automating claim management enables drug manufacturers
to enhance operational efficiency, reduce errors, and make the revenue cycles more efficient.
The application of AI in pharmaceutical manufacturing has already begun, with examples including the
use of machine vision technology to replace human visual inspection of packaging, caps, and vials;
predictive equipment maintenance to reduce disturbances, risks, and production downtime (12, 13); and
automated quality control, enabling seamless scheduling of analytical testing (14) and continuous process
quality assurance (15).
Role of Robotics in Pharmaceutical Industry
In recent years, the usage of Robotics has transformed multiple processes in the pharmaceutical industry,
offering increased precision, scalability, and safety.
Some of the key areas where robotics can contribute immensely in pharma are as follows:
Volume 1, Issue 1, November-December 2024
4
Journal of Next-Generation Research 5.0 (JNGR 5.0)
Website: www.jngr5.com Email: [email protected]
Laboratory Automation: Laboratories are areas where robots can greatly enhance efficiency. Robots
can effectively automate the liquid handling process and prepare compounds for testing purposes,
allowing laboratories to scale easily. Robotic systems are also used in clinical samples, where high-
throughput and accuracy are required to obtain more data needed for research and clinical trials.
Manufacturing: Pharmaceutical manufacturing is undergoing a paradigm shift with the help of robotics.
These advanced technologies can help companies in assembly lines, filling tasks, and final packaging
more efficiently. It has immense potential to enable companies to accelerate production while maintaining
consistency and lowering the risk of contamination.
Robotics-based systems can carry out various high-precision jobs like filling vials and ensuring proper
dosage without the risk of human error.
Robotics Compounding: With the help of robotics, pharmacies can automate the preparation and
dispensing of individualized medications. This technique enhances workflow efficiency and allows for
high-level, consistent, and error-free results. Automated robotic systems can be used in pharmacy
operations to support dispensing, medication packaging, and inventory management, thereby reducing
human errors and enhancing pharmacy workflow.
Distribution and Logistics: Warehousing processes involving sorting, picking, and packing materials are
automated using robotics to ensure greater efficiency and precision in medicine delivery. Mobile racks,
autonomous/nonautonomous mobile equipment, and robotic arms transport and lay systems inside the
warehouse unit.
Sterile Environments: Current uses of robotics are in sterile environments, such as the production of
injectable drugs and vaccines. Hygienic Processes: Robots precisely perform tasks such as vial inspection
or aseptic filling according to the highest hygiene and safety standards.
Robotics for pharmacy medication dispensing: Automated dispensing systems are revolutionizing the
management and distribution of medications in retail and hospital settings. These systems leverage
robotic arms and AI-integrated software to accurately pick, count, and pack prescriptions with exceptional
precision. These robotic systems minimize the chances of human mistakes, so patients receive the proper
medication and amount. By automating repetitive processes such as sorting and labeling, pharmacies can
enhance operational efficiency, decrease waiting times, and enable pharmacists to concentrate on patient
care and clinical consultations. Robotic dispensing systems can also integrate with inventory management
software to keep real-time stock levels and improve inventory of medication accuracy, which ultimately
helps in curtailing wastage. Robotics in pharmaceuticals does not only improve safety and precision.
Additionally, it can increase efficiency for maximum pharmacy operations, which are critical for cost
reductions and improved patient results. Internet of Things (IoT), artificial intelligence (AI), and robotic
advancements are continuously decreasing human interventions in drug discovery, synthetic chemistry,
and biotechnology laboratories (16). Robotics are used to assemble and package several medical devices
and implants. In addition, robotics are used to make prescriptions for mail-order pharmacies or hospitals
(17). A pharmacy automation system, PillPick helps hospitals eliminate the opportunity for medication
errors during packaging and dispensing - ultimately increasing patient safety. PillPick decreases human
touches in bar coding, packaging, storing, and dispensing unit dose medications.
By automating these tasks, packaging and dispensing systems enhance the efficiency of hospital
pharmacy operations while improving accuracy (18).
Volume 1, Issue 1, November-December 2024
5
Journal of Next-Generation Research 5.0 (JNGR 5.0)
Website: www.jngr5.com Email: [email protected]
Future Scope
The future of AI, automation, and robotics in pharma is expansive and transformative, with the potential
to change many aspects of drug development, manufacturing, and healthcare solutions.
Below are the areas of immense growth and opportunities:
Drug discovery and development powered by artificial intelligence: This field will keep evolving and
moving faster as AI helps analyze massive biological datasets, predict how drugs will interact, and find
new biological compounds ever more efficiently. With machine learning in its corner, the hope is that AI
can speed up the development of new and specific therapies and vaccines, potentially saving years off the
drug development timeline.
The AI function in biomarker identification and personalized medicine will be broadened, resulting in
more treatments that factor in patient genetic and environmental factors as well. This will maximize
efficacy and reduce unwanted reactions to treatment.
AI and Automation for Better Clinical Trials: AI will be essential in optimizing, designing, and
monitoring clinical trials and patient recruitment. AI can be used to match the best candidates more
efficiently by analyzing large data sets and improving trial outcomes with minimal bias. Implementing
automation for clinical trial operations will minimize human error, improve data collection, and make the
real-time monitoring of safety and efficacy much easier.
Automation and Robotics in Pharmacy: With the help of automation and robotics, pharmacy
operations will enhance efficiency in areas such as medication dispensing, inventory management, patient
counseling, and smart reminders. Further, AI, with its predictive algorithms, will enable pharmacists to
identify possible medication errors and potential drug interactions, improving patient safety.
Supply Chain Optimization: AI technologies are set to revolutionize pharmaceutical supply chains.
These technologies can enable companies to manage better inventory, stockout situations, and lower
wastage. Predictive analytics will help with logistics and demand forecasting, facilitating better resource
allocation and speed in distribution. As global healthcare demands continue to increase, robotics will
enhance warehouse efficiency by automating sorting, packing, and delivery, ensuring that medications are
delivered on time and in quantity. Overall, AI, automation, and robotics have the potential to discover
drugs faster, drive efficiencies in operations, and improve patient outcomes. However, various challenges
will require ongoing efforts between stakeholders throughout the pharma ecosystem to overcome; there is
a bright future for this space in the pharma industry, making healthcare more personal and within reach
for more people. Advancing and combining these biological fields will probably change the face of the
pharma world as we know it, allowing companies to meet the growing demand while ensuring
compliance and optimal patient experience (19).
Conclusion
To conclude, AI automation and robotics play a critical and inevitable role in the pharma industry, adding
substantial value through efficiency, accuracy, and innovation. Technological innovations include drug
discovery, manufacturing, clinical trials, and medication dispensing. With the ease of identifying drug
interactions, personalizing treatments, and scanning massive data sets, AI can offer a complete positive
transformation of the healthcare sector by ensuring quicker development of effective and safer therapies.
Further, automation and robotics improve operational efficiency as these minimize human error, improve
Volume 1, Issue 1, November-December 2024
6
Journal of Next-Generation Research 5.0 (JNGR 5.0)
Website: www.jngr5.com Email: [email protected]
production processes, and optimize supply chain management, thereby reducing costs and increasing the
overall quality of pharmaceutical products. With rapid evolution, the future of AI, automation, and
robotics in pharma is very bright. With the integration of these technologies, companies could run more
efficiently and innovate at a much higher pace. These innovations and advancements are much needed to
improve the overall healthcare ecosystem, meet the growing demands of customers, and sustain growth in
this hyper-competitive world.
References:
1. Patel H. A Review: Future Aspects of Artificial Intelligence, Big Data, and Robotics in the
Pharmaceutical Industry. 2021.
2. Mouratidis Y. An insight of AI’s penetration in drug development market [Internet]. 2018 Nov 30.
Available from: https://www.forbes.com/
3. Sunarti S, Rahman FF, Naufal M, Risky M, Febriyanto K, Masnina R. Artificial intelligence in
healthcare: Opportunities and risks for the future. Gac Sanit. 2021;35(Suppl 1):S67–S70.
4. Toepper M. Dissociating normal aging from Alzheimer’s disease: A view from cognitive neuroscience.
J Alzheimer’s Dis. 2017;57:331–352.
5. Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Futur Healthc J.
2019;6:94–98.
6. Fakoor R, Ladhak F, Nazi A, Huber M. Using deep learning to enhance cancer diagnosis and
classification. In: Proceedings of the International Conference on Machine Learning; 2013 Jun 16–21;
Atlanta, GA, USA.
7. Vial A, Stirling D, Field M, Ros M, Ritz C, Carolan M, et al. The role of deep learning and radiomic
feature extraction in cancer-specific predictive modelling: A review. Transl Cancer Res. 2018;7:803–816.
8. Bhattamisra SK, Banerjee P, Gupta P, Mayuren J, Patra S, Candasamy M. Artificial intelligence in
pharmaceutical and healthcare research. Big Data Cogn Comput. 2023;7(1):10.
doi:10.3390/bdcc7010010.
9. Snyder J. New machine vision technology focuses on performance, ease of use, lower costs. Chilton's I
& CS. 1995;68(12):25–28.
10. Veillon R. Years of visual inspection: Where do we go from here? PDA Letter.
11. Pokhriyal P, Chavda VP, Pathak M. Future prospects and challenges in the implementation of AI and
ML in pharma sector. Bioinformatics tools for pharmaceutical drug product development. 2023:401–416.
12. Otto S. The case for predictive maintenance. Pharma Manuf. 2019.
13. Hamann H, Markarian C, Meyer auf der Heide F, Wahby M. Pick, pack, & survive: Charging robots
in a modern warehouse based on online connected dominating sets. In: 9th International Conference on
Fun with Algorithms (FUN 2018). Schloss Dagstuhl-Leibniz-Zentrum fuer Informatik; 2018.
14. Han Y, Makarova E, Ringel M, Telpis V. Digitization, automation, and online testing: The future of
pharma quality control. McKinsey & Company Report. 2019.
15. Chapman J. How AI tools will transform quality management in the life sciences. Pharmaceutical.
2019.
Volume 1, Issue 1, November-December 2024
7
Journal of Next-Generation Research 5.0 (JNGR 5.0)
Website: www.jngr5.com Email: [email protected]
16. Saharan VA. Robotic automation of pharmaceutical and life science industries. In: Saharan VA,
editor. Computer aided pharmaceutics and drug delivery. Singapore: Springer; 2022. doi:10.1007/978-
981-16-5180-9_12.
17. Brumson B. Robotics in the pharmaceutical and life sciences industry. Robotic Industries Association.
2011.
18. Garriga J. Warehouse and robotic pharmaceutical dispensing system. 2010.
19. Ramdurai B. Growing importance of patient engagement in healthcare. Int J Nurs Health Sci.
2020;6(3):1–9.
Volume 1, Issue 1, November-December 2024